Patent classifications
A61K36/575
TRADITIONAL CHINESE MEDICINE COMPOSITION FOR TREATING NOVEL CORONAVIRUS PNEUMONIA, PREPARATION METHOD, DETECTION METHOD, AND USE THEREOF
Provided in the present disclosure are a traditional Chinese medicine composition for treating novel coronavirus pneumonia, a preparation method, a detection method, and the use thereof. The traditional Chinese medicine composition is mainly prepared from the following raw materials in parts by weight: 250-400 parts of Citri reticulatae pericarpium, 100-200 parts of Atractylodis rhizoma, 100-200 parts of Magnoliae officinalis cortex, 200-300 parts of Glycyrrhizae radix et rhizoma, 200-300 parts of Agastache rugosus, 200-300 parts of Acori tatarinowii rhizoma, 250-330 parts of Jujubae fructus, and 100-200 parts of Zingiberis rhizoma recens. Further provided in the present disclosure are a preparation method and a detection method for the traditional Chinese medicine composition.
TRADITIONAL CHINESE MEDICINE COMPOSITION FOR TREATING NOVEL CORONAVIRUS PNEUMONIA, PREPARATION METHOD, DETECTION METHOD, AND USE THEREOF
Provided in the present disclosure are a traditional Chinese medicine composition for treating novel coronavirus pneumonia, a preparation method, a detection method, and the use thereof. The traditional Chinese medicine composition is mainly prepared from the following raw materials in parts by weight: 250-400 parts of Citri reticulatae pericarpium, 100-200 parts of Atractylodis rhizoma, 100-200 parts of Magnoliae officinalis cortex, 200-300 parts of Glycyrrhizae radix et rhizoma, 200-300 parts of Agastache rugosus, 200-300 parts of Acori tatarinowii rhizoma, 250-330 parts of Jujubae fructus, and 100-200 parts of Zingiberis rhizoma recens. Further provided in the present disclosure are a preparation method and a detection method for the traditional Chinese medicine composition.
TRADITIONAL CHINESE MEDICINE COMPOSITION FOR TREATING NOVEL CORONAVIRUS PNEUMONIA, PREPARATION METHOD, DETECTION METHOD, AND USE THEREOF
Provided in the present disclosure are a traditional Chinese medicine composition for treating novel coronavirus pneumonia, a preparation method, a detection method, and the use thereof. The traditional Chinese medicine composition is mainly prepared from the following raw materials in parts by weight: 250-400 parts of Citri reticulatae pericarpium, 100-200 parts of Atractylodis rhizoma, 100-200 parts of Magnoliae officinalis cortex, 200-300 parts of Glycyrrhizae radix et rhizoma, 200-300 parts of Agastache rugosus, 200-300 parts of Acori tatarinowii rhizoma, 250-330 parts of Jujubae fructus, and 100-200 parts of Zingiberis rhizoma recens. Further provided in the present disclosure are a preparation method and a detection method for the traditional Chinese medicine composition.
Oral compositions containing enhanced antibacterial combinations of antioxidants and extracts of magnolia
An oral composition contains an enhanced antibacterial effective amount of an antioxidant and an extract of Magnolia.
Oral compositions containing enhanced antibacterial combinations of antioxidants and extracts of magnolia
An oral composition contains an enhanced antibacterial effective amount of an antioxidant and an extract of Magnolia.
Oral compositions containing enhanced antibacterial combinations of antioxidants and extracts of magnolia
An oral composition contains an enhanced antibacterial effective amount of an antioxidant and an extract of Magnolia.
Oral care compositions
Disclosed herein are methods of enhancing the solubility and delivery of one or more active ingredients found in magnolia extract, or a synthetic analog thereof, in an oral composition.
Oral care compositions
Disclosed herein are methods of enhancing the solubility and delivery of one or more active ingredients found in magnolia extract, or a synthetic analog thereof, in an oral composition.
Oral care compositions
Disclosed herein are methods of enhancing the solubility and delivery of one or more active ingredients found in magnolia extract, or a synthetic analog thereof, in an oral composition.
Manufacturing method of an herbal medicinal tablet formulation for treating obesity which can be prescribed based on sasang constitutional medicine
An embodiment of the present invention provides a manufacturing method of an herbal medicinal tablet formulation for treating obesity which is prescribed based on Sasang constitutional medicine, comprises manufacturing a concentrated ephedra powder agent so that an ephedrine content is 3.0-4.0%; determining a weight of the concentrated ephedra powder agent according to each constitution of Sasang constitutional medicine, and manufacturing a side effect-preventing powder agent for each constitution to prevent and suppress side effects according to constitution of Sasang constitutional medicine with respect to the weight of the concentrated ephedra powder agent; mixing the concentrated ephedra powder agent and the side effect-preventing powder agent with a variance of a weight ratio therebetween in consideration of weight, obesity, constitution of Sasang constitutional medicine, and side effects; and tableting the mixture of the prepared ephedra powder agent and side effect-preventing powder agent.